Molecular diagnostic assay for influenza virus detection with high sensitivity and specificity. Designed for rapid identification of influenza infections in clinical settings.
Manufactured by
Guangzhou Guangdong, China
Deaou Gene Technology Co., Ltd. (established on December 9, 2021) is an innovative high-tech company incubated by GUANGZHOU DEAOU BIO-TECHNOLOGY CO.,LTD. The company is committed to the research and development, as well as the industrialization, of fully automated molecular testing technology platforms, mainly focusing on IVD (in vitro diagnostic) instruments and reagent kits. With an independently developed technology platform, Deaou Gene has obtained multiple patents across various countries, covering major markets in Europe, South America, Asia, and other regions. The company's solutions encompass testing consumables, reagents, and instrument technologies, with core technical advantages, especially in reagent kit design, multi-color melting curve, and fluorescence detection.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 3 relevant products
Qassay
United States · 1 relevant product
Applied Biocode, Inc.
United States · 2 relevant products
75 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 114 closest product alternatives
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid and accurate diagnostic test for simultaneous detection of influenza and COVID-19 at the point of care. Enables differentiation between respiratory pathogens in 20 minutes.
Qassay · United States
Advanced assay for detecting biomarkers associated with infectious diseases. Enables rapid diagnostic testing in point-of-care settings.
Applied Biocode, Inc. · United States
A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
111 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products